Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.
about
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious InflammationPromising Therapy Candidates for Liver FibrosisMitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion InjuryTargeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic SteatohepatitisThe spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE.WISP1 mediates hepatic warm ischemia reperfusion injury via TLR4 signaling in mice.Superoxide induces Neutrophil Extracellular Trap Formation in a TLR-4 and NOX-dependent mechanism.Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases.Starring role of toll-like receptor-4 activation in the gut-liver axis.Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion.Ischemic preconditioning modulates ROS to confer protection in liver ischemia and reperfusion.Toll-Like Receptor Signaling in Burn Wound Healing and Scarring.Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms.Differential Effects of Three Techniques for Hepatic Vascular Exclusion during Resection for Liver Cirrhosis on Hepatic Ischemia-Reperfusion Injury in Rats.High-Mobility Group Box-1 and Liver Disease
P2860
Q26747005-3F029108-7281-4B40-9FAD-1AE6A4C3EB6EQ26766727-FA8489CC-03C8-421C-BEBD-CED6D523C8AEQ26771761-C3F2B2B1-79A5-4F3E-86CE-85E12C2AA09DQ28077079-EEF3D781-8336-4512-9312-B7899B32B619Q30275901-A2125CF1-2784-49E7-9592-98424B8A3DD4Q36517021-8091FFD2-CD90-4FF0-91B1-BF0453F05E5DQ37370570-9F52953E-615E-4620-9B57-0FA8C1E9B4C9Q38521537-7AC50A1B-FC55-467D-A4F2-DCD7F52C7756Q38645789-F0B392E0-09BE-43E0-AA07-46FD4CE459EDQ39012727-5F720402-3496-4E53-9DB0-F838C2F11D34Q39181911-59121450-40FD-497C-8048-FBDDDB6291ABQ39427034-865E9217-C1DA-46C9-8DF4-32412F89A0C3Q45415293-A1CD1FF4-1A9F-4DA9-8E23-05378BC1473EQ46269173-8CD1827C-00CE-47D4-9021-D93BB381CB77Q54936249-EC6DE0F8-3AB6-4510-8908-8624ED5DA08CQ58760274-DDC16E72-775C-4DF8-A3B8-CDA68F93E998
P2860
Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@ast
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@en
type
label
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@ast
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@en
prefLabel
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@ast
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@en
P2093
P2860
P1433
P1476
Toll-like receptor 4 (TLR4) an ...... protein B1 (HMGB1) signaling.
@en
P2093
Allan Tsung
Kerry-Ann Mcdonald
Kimberly Ferrero
Patricia Loughran
Samer Tohme
Timothy Billiar
P2860
P2888
P304
P356
10.2119/MOLMED.2014.00076
P407
P577
2014-01-01T00:00:00Z
P6179
1078999258